Los Angeles, CANCT06447168Now EnrollingIRB Ready

Primary Biliary Cholangitis Clinical Trial in Los Angeles, CA

Access cutting-edge primary biliary cholangitis treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.

Sponsored by Ipsen

Quick Self-Assessment

See if you qualify for this Los Angeles location

Preparing your pre-screening questions…

Expert Care in Los Angeles

Access primary biliary cholangitis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related primary biliary cholangitis treatment provided free

Apply for This Los Angeles Location

Check if you qualify for this primary biliary cholangitis clinical trial in Los Angeles, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Los Angeles

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Los Angeles site if eligible
  4. 4Begin participation

About This Primary Biliary Cholangitis Study in Los Angeles

This study will collect information from participants with Primary Biliary Cholangitis (PBC) as they use the drug elafibranor in real world setting. PBC is a progressive rare liver disease in which tubes in the liver called bile ducts are damaged. The liver damage in PBC may lead to scarring (cirrhosis). PBC may also be associated with multiple symptoms including pruritus (itching) and fatigue. Many patients with PBC may require liver transplant or may die if the disease progresses and a liver transplant is not done. In this study the main aim is to observe the effectiveness, safety and tolerability of elafibranor in participants with PBC who are receiving treatment in real world setting. The total study duration for each participants will be 60 months (approximately 5 years).

Sponsor: Ipsen

Who Can Participate

Inclusion Criteria

Participant has provided written informed consent and agrees to comply with the study protocol.
Participant with PBC diagnosis.
Participant for whom the treating physician has decided to start or participants who are currently receiving treatment with commercialized elafibranor.
If a participant has a caregiver who agrees to complete the caregiver questionnaires, an informed consent should be collected from the caregiver before any data is collected.

Exclusion Criteria

Participant is currently participating or, plans to participate in an investigational drug study or medical device study containing active substance.
Participant with known hypersensitivity to the product or to any of its excipients.
Participant with mental instability or incompetence, such that the validity of informed consent or ability to be compliant with the study is uncertain.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Los Angeles?

Yes, this clinical trial (NCT06447168) has an active research site in Los Angeles, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Primary Biliary Cholangitis Treatment Options in Los Angeles, CA

If you're searching for primary biliary cholangitis treatment options in Los Angeles, CA, this clinical trial (NCT06447168) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced primary biliary cholangitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all primary biliary cholangitis clinical trials near you to find additional studies recruiting in your area.

More Primary Biliary Cholangitis Trials in Los Angeles, CA

See all primary biliary cholangitis clinical trials recruiting in Los Angeles — not just this study.

Browse Primary Biliary Cholangitis Trials in Los Angeles →

Browse More Trials by Condition

Primary Biliary Cholangitis TrialsAll Conditions →

Ready to Join in Los Angeles?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Los Angeles, CA